Cargando…

Let’s rethinking about the safety of phosphodiesterase type 5 inhibitor in the patients with erectile dysfunction after radical prostatectomy

As the radical prostatectomy (RP) for the patient diagnosed as localized prostate cancer has been increasing, erectile dysfunction (ED) associated with RP is increased and ED after RP is a significant risk factor to reduce the quality of life for the patient after RP. Therefore, the treatment concep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Su Jin, Kim, Ju Ho, Chang, Hyun-Kyung, Kim, Khae Hawn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Exercise Rehabilitation 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4934956/ https://www.ncbi.nlm.nih.gov/pubmed/27419107 http://dx.doi.org/10.12965/jer.1632646.323

Ejemplares similares

Phosphodiesterase type 5 inhibitors for the treatment of post-nerve sparing radical prostatectomy erectile dysfunction in men
por: Li, Jinhong, et al.
Publicado: (2014)

Phosphodiesterase type-5 inhibitors for erectile dysfunction following nerve-sparing radical prostatectomy: A network meta-analysis
por: Yang, Jie, et al.
Publicado: (2021)

Efficacy of phosphodiesterase type 5 inhibitors in patients with erectile dysfunction after nerve-sparing radical prostatectomy: a systematic review and meta-analysis
por: Goh, Hyeok Jun, et al.
Publicado: (2022)

Let's Pay Attention to the Average
por: Kim, Khae Hawn
Publicado: (2014)

Management of erectile dysfunction post-radical prostatectomy
por: Saleh, Alan, et al.
Publicado: (2015)

Systematic Review and Meta-Analysis of the Use of Phosphodiesterase Type 5 Inhibitors for Treatment of Erectile Dysfunction following Bilateral Nerve-Sparing Radical Prostatectomy
por: Wang, Xiao, et al.
Publicado: (2014)

Erectile dysfunction in robotic radical prostatectomy: Outcomes and management
por: Whelan, Patrick, et al.
Publicado: (2014)

The paradox of erectile dysfunction data after radical prostatectomy
por: Moretti, Tomás Bernardo Costa, et al.
Publicado: (2022)

Incontinence and Erectile Dysfunction Following Radical Prostatectomy: A Review
por: Alivizatos, Gerasimos, et al.
Publicado: (2005)

Effect of Nerve-Sparing Radical Prostatectomy on Urinary Continence in Patients With Preoperative Erectile Dysfunction
por: Park, Yong Hyun, et al.
Publicado: (2016)

Does early depressive mood expire following radical retropubic prostatectomy in patients with localized prostate cancer?
por: Chung, Kyung Jin, et al.
Publicado: (2019)

Regenerative Medicine for Erectile Dysfunction Following Radical Prostatectomy: Are we Ready?
por: Albersen, Maarten, et al.
Publicado: (2016)

Post Radical Prostatectomy Erectile Dysfunction. A Single Centre Experience
por: Pikramenos, Konstantinos, et al.
Publicado: (2023)

Efficacy and safety of short- and long-term, regular and on-demand regimens of phosphodiesterase type 5 inhibitors in treating erectile dysfunction after nerve-sparing radical prostatectomy: a systematic review and meta-analysis
por: Tian, Daxue, et al.
Publicado: (2017)

Erectile dysfunction and heart failure: the role of phosphodiesterase type 5 inhibitors
por: Al-Ameri, H, et al.
Publicado: (2009)

Preference for and adherence to oral phosphodiesterase-5 inhibitors in the treatment of erectile dysfunction
por: Giannitsas, Konstantinos, et al.
Publicado: (2008)

Chronic Low Dosing of Phosphodiesterase Type 5 Inhibitor for Erectile Dysfunction
por: Sung, Hyun Hwan, et al.
Publicado: (2012)

The devil is in the details: an analysis of the subtleties between phosphodiesterase inhibitors for erectile dysfunction
por: Smith-Harrison, L.I., et al.
Publicado: (2016)

Pathophysiology of visual disorders induced by phosphodiesterase inhibitors in the treatment of erectile dysfunction
por: Moschos, Marilita M, et al.
Publicado: (2016)

Erectile dysfunction post-radical prostatectomy – a challenge for both patient and physician
por: Bratu, O, et al.
Publicado: (2017)

Effects of Biofeedback in Preventing Urinary Incontinence and Erectile Dysfunction after Radical Prostatectomy
por: Perez, Fabiana S. B., et al.
Publicado: (2018)

The assessment of erectile dysfunction after radical prostatectomy using pudendal somatosensory evoked potential
por: Kwon, Se Yun, et al.
Publicado: (2023)

Endothelial Dysfunction, Erectile Dysfunction and Phosphodiesterase 5 Inhibitors. An Update of the Current Data and Future Perspectives
por: Konstantinopoulos, Angelis, et al.
Publicado: (2007)

The Efficacy and Safety of Tadalafil 5 mg Once Daily in the Treatment of Erectile Dysfunction After Robot-Assisted Laparoscopic Radical Prostatectomy: 1-Year Follow-up
por: Seo, Young Eun, et al.
Publicado: (2014)

Prevention and management of post prostatectomy erectile dysfunction
por: Salonia, Andrea, et al.
Publicado: (2015)

Does penile rehabilitation have a role in the treatment of erectile dysfunction following radical prostatectomy?
por: Blecher, Gideon, et al.
Publicado: (2017)

Efficacy and Safety of Tadalafil 5 mg Once Daily for the Treatment of Erectile Dysfunction After Robot-Assisted Laparoscopic Radical Prostatectomy: A 2-Year Follow-Up
por: Kim, Soodong, et al.
Publicado: (2018)

Longitudinal recovery patterns of penile length and the underexplored benefit of long-term phosphodiesterase-5 inhibitor use after radical prostatectomy
por: Kwon, Young Suk, et al.
Publicado: (2018)

Phosphodiesterase type 5 inhibitors as a treatment for erectile dysfunction: Current information and new horizons
por: Ferguson, James E., et al.
Publicado: (2013)

A comparison of the available phosphodiesterase-5 inhibitors in the treatment of erectile dysfunction: a focus on avanafil
por: Evans, Jeffery D, et al.
Publicado: (2015)

Efficacy of Low-Intensity Extracorporeal Shock Wave Treatment in Erectile Dysfunction Following Radical Prostatectomy: A Systematic Review and Meta-Analysis
por: Rho, Beom Yong, et al.
Publicado: (2022)

Erratum: Acknowledgments. The Efficacy and Safety of Tadalafil 5 mg Once Daily in the Treatment of Erectile Dysfunction After Robot-Assisted Laparoscopic Radical Prostatectomy: 1-Year Follow-up
por: Seo, Young Eun, et al.
Publicado: (2014)

AB032. Penile rehabilitation using Vacuum Erection Device for erectile dysfunction after radical prostatectomy
por: Ye, Dingwei, et al.
Publicado: (2015)

AB003. Erectile dysfunction (ED) after radical prostatectomy: mile stones in development of rehabilitation strategy
por: Wang, Run, et al.
Publicado: (2015)

Penile Rehabilitation and Treatment Options for Erectile Dysfunction Following Radical Prostatectomy and Radiotherapy: A Systematic Review
por: Nicolai, Melianthe, et al.
Publicado: (2021)

Surgical Techniques for Managing Post-prostatectomy Erectile Dysfunction
por: Castiglione, Fabio, et al.
Publicado: (2017)

Clinical Approach to Recurrent Voiding Dysfunction, Dysuria, and Pelvic Pain Persisting for at Least 3 Months
por: Kim, Su Jin, et al.
Publicado: (2022)

The science of vacuum erectile device in penile rehabilitation after radical prostatectomy
por: Lin, Haocheng, et al.
Publicado: (2013)

Toward a new ‘EPOCH’: optimising treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction
por: Sadovsky, R, et al.
Publicado: (2009)

Inflammatory biomarkers may predict response to phosphodiesterase type 5 inhibitor treatment in patients with erectile dysfunction
por: Kilic, Metin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q493k4rd5il8bd1l03673dgq77